image

The best stocks to buy since 1993

Our latest issue will be released in 13 days, don't miss out!

Volex - New 5 year target to drive margin to 12%

August 2026

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • VLX
  • Price:
  • 523p
Volex has completed its five-year plan (laid out in June 2022), a full 12 months ahead of schedule. Sales hit a record US$1,243m, up 14%, with organic growth of 14.2%. Operating profit rose 20% to US$127.3m, driving the margin to 10.2%, breaking the top end of the previous 9-10% range.  The swing factor was Complex Industrial, up 56% organically to US$382.9m. Inside that, there’s the Data Centre bit where revenues doubled to US$240m - all those greedy data centres need proper, reliable, don’t-blow-up-in-my-face high-speed 200G/400G copper interconnects for their AI training. Volex is feeding that monster. Hyperscalers (Microsoft, Amazon, Google/Alphabet, Meta, Oracle, etc) are investing hundreds of billions in combined capex for 2 ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe